Part of Phaidon International
Part of Phaidon International
Showing 17 results
Sort by:
Senior / Staff Machine Learning Research EngineerLocation: San Francisco Bay Area (Hybrid)Level: Senior or StaffReports to: Head of Machine Learning The Opportunity:A well-resourced, research-driven biotechnology organization is building out a dedicated Machine Learning Research Engineering function to support the development of cutting-edge machin...
Senior / Staff Machine Learning Research EngineerLocation: San Francisco Bay Area (Hybrid)Level: Senior or StaffReports to: Head of Machine Learning The OpportunityA well-resourced, research-driven technology organization is building out a dedicated Machine Learning Research Engineering function to support the development of cutting-edge machine le...
Contract R&D Mechanical Design EngineerLocation: Eindhoven, Netherlands (Hybrid) Contract Length: 12 Months Initial ContractOverviewOur client is seeking an experienced R&D Engineer to support the development of next-generation medical devices within a highly regulated Med-Tech environment.The successful contractor will work as part of a multidisci...
Senior Clinical Trial Manager | Waltham, MA$150k-$185kOur client is a well-funded, publicly traded clinical-stage biotechnology company developing next-generation biologics for chronic inflammatory diseases. With multiple late-stage clinical programs and substantial capital to support growth, the organization is entering an exciting phase of expans...
Title: Director, Clinical PharmacologyLocation: Greater Philadelphia Area (Hybrid)A growing biotechnology company is seeking a Director of Clinical Pharmacology to drive clinical pharmacology and MIDD strategies across its pipeline. This role will be responsible for supporting programs from Phase 1 through registration, leveraging quantitative phar...
Senior Clinical Trial Manager | Waltham, MA$150k-$185kOur client is a well-funded, publicly traded clinical-stage biotechnology company developing next-generation biologics for chronic inflammatory diseases. With multiple late-stage clinical programs and substantial capital to support growth, the organization is entering an exciting phase of expans...